ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2022

Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience.

Çağdaş Erdoğan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.